- Report
- November 2021
- 620 Pages
Global
From €3541EUR$4,000USD£3,067GBP
The Virus Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat viral infections. These drugs are designed to target specific viruses, such as HIV, hepatitis, and influenza, and can be used to treat both acute and chronic infections. They can also be used to prevent the spread of viruses, such as through vaccinations.
The Virus Drug market is highly competitive, with many companies vying for market share. Companies in the market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, Johnson & Johnson, Bristol-Myers Squibb, and Novartis. These companies are engaged in research and development of new drugs, as well as the marketing and sale of existing drugs. Show Less Read more